Clinical trials: sponsored by Power Life Sciences Inc.
Tinnitus
Assessing Factors in Tinnitus Patients' Clinical Study Experiences
Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical trials, both positive and negative.
- Trial name
- NCT05811871
- Volunteers
- 500 people
- Sponsor
- Power Life Sciences Inc.
Head and Neck Cancer
Discovering Factors in Head and Neck Cancer Patients' Clinical Study Experiences
Enrollment in clinical trials usually favors a particular demographic group. But there is limited research available to explain what study attributes affect the completion of these specific demographic groups.
- Trial name
- NCT05801770
- Volunteers
- 500 people
- Sponsor
- Power Life Sciences Inc.
Ovarian Cancer
Appraising Medical Trial Experiences of Ovarian Cancer Patients
Historically, participation in clinical trials has been highly skewed towards specific demographic groups. However, research identifying which trial attributes impact participation, in either positive or negative ways, is…
- Trial name
- NCT05801796
- Volunteers
- 500 people
- Sponsor
- Power Life Sciences Inc.
Small Cell Lung Cancer
Examining Clinical Trial Participation for Small Cell Lung Cancer Patients
Clinical study participation percentages haven't always been fully representative of a given demographic. The goal is to find out which aspects of a clinical trial may make it more difficult for patients to take part or see it…
- Trial name
- NCT05769504
- Volunteers
- 500 people
- Sponsor
- Power Life Sciences Inc.
Cervical Cancer
Discovering Factors in Cervical Cancer Patients' Clinical Trial Experiences
The percentages of participants in clinical studies haven't always been perfectly representative of a particular group. This research examines the variables that affect a patient's choice to enroll in, discontinue participation…
- Trial name
- NCT05789628
- Volunteers
- 500 people
- Sponsor
- Power Life Sciences Inc.
Non-Small Cell Lung Cancer
Examination of Trends in Non-Small Cell Lung Cancer Patients' Medical Study Experiences
Medical study participation percentages haven't always been fully representative of a given demographic. The goal is to find out which aspects of a clinical trial may make it more difficult for patients to take part or see it…
- Trial name
- NCT05778045
- Volunteers
- 500 people
- Sponsor
- Power Life Sciences Inc.
Triple Negative Breast Cancer, Breast Cancer
Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials
Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical trials, both positive and negative.
- Trial name
- NCT05769491
- Volunteers
- 500 people
- Sponsor
- Power Life Sciences Inc.
Bile Duct Cancer
Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials
Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical trials, both positive and negative.
- Trial name
- NCT05706974
- Volunteers
- 500 people
- Sponsor
- Power Life Sciences Inc.
Leiomyosarcoma
Exploring Clinical Trial Experiences of People With Leiomyosarcoma
Clinical study participation has historically been heavily biased toward specific demographics. Several people will be invited to enroll in this study so that it may collect a variety of data about leiomyosarcoma clinical trial…
- Trial name
- NCT05548179
- Volunteers
- 500 people
- Sponsor
- Power Life Sciences Inc.
Cholangiocarcinoma
Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma
The main reason for conducting this research is to gain a better understanding of why some people with cholangiocarcinoma are not able to participate in or complete clinical trials.
- Trial name
- NCT05694845
- Volunteers
- 500 people
- Sponsor
- Power Life Sciences Inc.
Lung Cancer, Non-small Cell
Neoadjuvant Immunotherapy in Advanced NSCLC
A number of clinical trials have demonstrated the efficacy of immunotherapy prior as neoadjuvant therapy. This study evaluates whether said neoadjuvant immunotherapy may improve improve progression free survival in NSCLC.
- Trial name
- NCT05137912
- Testing
- Immunotherapy
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Power Life Sciences Inc.